Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma

To determine whether CD44, which is associated with tumor growth and metastasis, is related to carcinogenesis and prognosis in ovarian mucinous carcinomas (MACs). Tissue blocks from 71 patients with benign mucinous ovarian tumors were used in the study: 35 were from patients with borderline mucinous...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2018-02, Vol.38 (2), p.717
Main Authors: Matuura, Hiroko, Miyamoto, Morikazu, Takano, Masashi, Soyama, Hiroaki, Aoyama, Tadashi, Yoshikawa, Tomoyuki, Kato, Kento, Sakamoto, Takahiro, Kuwahara, Mika, Takasaki, Kazuki, Ishibashi, Hiroki, Iwahashi, Hideki, Tsuda, Hitoshi, Furuya, Kenichi
Format: Article
Language:English
Subjects:
Benign
Carcinogenesis
Carcinogens
CD44 antigen
Medical prognosis
Metastases
Ovarian cancer
Ovarian carcinoma
Patients
Prognosis
Survival
Tumorigenesis
Tumors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c372t-2dfb95d5cc8fad88c195ce050317b94a784de6d6b9e7fa72e1e151133bec512e3
cites
container_end_page
container_issue 2
container_start_page 717
container_title Anticancer research
container_volume 38
creator Matuura, Hiroko
Miyamoto, Morikazu
Takano, Masashi
Soyama, Hiroaki
Aoyama, Tadashi
Yoshikawa, Tomoyuki
Kato, Kento
Sakamoto, Takahiro
Kuwahara, Mika
Takasaki, Kazuki
Ishibashi, Hiroki
Iwahashi, Hideki
Tsuda, Hitoshi
Furuya, Kenichi
description To determine whether CD44, which is associated with tumor growth and metastasis, is related to carcinogenesis and prognosis in ovarian mucinous carcinomas (MACs). Tissue blocks from 71 patients with benign mucinous ovarian tumors were used in the study: 35 were from patients with borderline mucinous ovarian tumors, and 60 from patients with MACs. Immunochemical analysis was performed to evaluate the expression of CD44 and examine its association with tumorigenesis and survival. Compared to benign tumors, borderline tumors had high CD44 expression levels (p=0.047). Conversely, MACs had lower expression than borderline tumors (p=0.032). Progression-free and overall survival of patients with MAC with low CD44 expression were worse than those of patients with high expression (p=0.04 and p=0.02, respectively). Malignant transformation of mucinous tumors is associated with changes in CD44 expression, with low expression level being a prognostic factor in MAC.
doi_str_mv 10.21873/anticanres.12277
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2137115439</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2137115439</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-2dfb95d5cc8fad88c195ce050317b94a784de6d6b9e7fa72e1e151133bec512e3</originalsourceid><addsrcrecordid>eNpFkMtOwzAQRS0EoqXwAWyQJdYpHjuO4yUKLVQqahewthzHQamoHeyEx9-TlgKbmVmce0c6CF0CmVLIBbvRrmuMdsHGKVAqxBEag5CQCM7IMRoTykkiCOEjdBbjhpAskzk7RSMqmUgzycdILf0Hnn22Q0VsvMO-xsVdmuJFxNrhhatsa4fhOjzXpvNhB6z9sNfBvzgfm4gbh1fvOjQD_9ibxvk-4kKH3bXV5-ik1q_RXhz2BD3PZ0_FQ7Jc3S-K22VimKBdQqu6lLzixuS1rvLcgOTGEk4YiFKmWuRpZbMqK6UVtRbUggUOwFhpDQdq2QRd__S2wb_1NnZq4_vghpeKAhMAPGVyoOCHMsHHGGyt2tBsdfhSQNReqfpXqvZKh8zVobkvt7b6S_w6ZN-AS3R9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2137115439</pqid></control><display><type>article</type><title>Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma</title><source>Free E-Journal (出版社公開部分のみ）</source><creator>Matuura, Hiroko ; Miyamoto, Morikazu ; Takano, Masashi ; Soyama, Hiroaki ; Aoyama, Tadashi ; Yoshikawa, Tomoyuki ; Kato, Kento ; Sakamoto, Takahiro ; Kuwahara, Mika ; Takasaki, Kazuki ; Ishibashi, Hiroki ; Iwahashi, Hideki ; Tsuda, Hitoshi ; Furuya, Kenichi</creator><creatorcontrib>Matuura, Hiroko ; Miyamoto, Morikazu ; Takano, Masashi ; Soyama, Hiroaki ; Aoyama, Tadashi ; Yoshikawa, Tomoyuki ; Kato, Kento ; Sakamoto, Takahiro ; Kuwahara, Mika ; Takasaki, Kazuki ; Ishibashi, Hiroki ; Iwahashi, Hideki ; Tsuda, Hitoshi ; Furuya, Kenichi</creatorcontrib><description>To determine whether CD44, which is associated with tumor growth and metastasis, is related to carcinogenesis and prognosis in ovarian mucinous carcinomas (MACs). Tissue blocks from 71 patients with benign mucinous ovarian tumors were used in the study: 35 were from patients with borderline mucinous ovarian tumors, and 60 from patients with MACs. Immunochemical analysis was performed to evaluate the expression of CD44 and examine its association with tumorigenesis and survival. Compared to benign tumors, borderline tumors had high CD44 expression levels (p=0.047). Conversely, MACs had lower expression than borderline tumors (p=0.032). Progression-free and overall survival of patients with MAC with low CD44 expression were worse than those of patients with high expression (p=0.04 and p=0.02, respectively). Malignant transformation of mucinous tumors is associated with changes in CD44 expression, with low expression level being a prognostic factor in MAC.</description><identifier>ISSN: 0250-7005</identifier><identifier>EISSN: 1791-7530</identifier><identifier>DOI: 10.21873/anticanres.12277</identifier><identifier>PMID: 29374695</identifier><language>eng</language><publisher>Greece: International Institute of Anticancer Research</publisher><subject>Benign ; Carcinogenesis ; Carcinogens ; CD44 antigen ; Medical prognosis ; Metastases ; Ovarian cancer ; Ovarian carcinoma ; Patients ; Prognosis ; Survival ; Tumorigenesis ; Tumors</subject><ispartof>Anticancer research, 2018-02, Vol.38 (2), p.717</ispartof><rights>Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</rights><rights>Copyright International Institute of Anticancer Research Feb 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-2dfb95d5cc8fad88c195ce050317b94a784de6d6b9e7fa72e1e151133bec512e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29374695$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matuura, Hiroko</creatorcontrib><creatorcontrib>Miyamoto, Morikazu</creatorcontrib><creatorcontrib>Takano, Masashi</creatorcontrib><creatorcontrib>Soyama, Hiroaki</creatorcontrib><creatorcontrib>Aoyama, Tadashi</creatorcontrib><creatorcontrib>Yoshikawa, Tomoyuki</creatorcontrib><creatorcontrib>Kato, Kento</creatorcontrib><creatorcontrib>Sakamoto, Takahiro</creatorcontrib><creatorcontrib>Kuwahara, Mika</creatorcontrib><creatorcontrib>Takasaki, Kazuki</creatorcontrib><creatorcontrib>Ishibashi, Hiroki</creatorcontrib><creatorcontrib>Iwahashi, Hideki</creatorcontrib><creatorcontrib>Tsuda, Hitoshi</creatorcontrib><creatorcontrib>Furuya, Kenichi</creatorcontrib><title>Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>To determine whether CD44, which is associated with tumor growth and metastasis, is related to carcinogenesis and prognosis in ovarian mucinous carcinomas (MACs). Tissue blocks from 71 patients with benign mucinous ovarian tumors were used in the study: 35 were from patients with borderline mucinous ovarian tumors, and 60 from patients with MACs. Immunochemical analysis was performed to evaluate the expression of CD44 and examine its association with tumorigenesis and survival. Compared to benign tumors, borderline tumors had high CD44 expression levels (p=0.047). Conversely, MACs had lower expression than borderline tumors (p=0.032). Progression-free and overall survival of patients with MAC with low CD44 expression were worse than those of patients with high expression (p=0.04 and p=0.02, respectively). Malignant transformation of mucinous tumors is associated with changes in CD44 expression, with low expression level being a prognostic factor in MAC.</description><subject>Benign</subject><subject>Carcinogenesis</subject><subject>Carcinogens</subject><subject>CD44 antigen</subject><subject>Medical prognosis</subject><subject>Metastases</subject><subject>Ovarian cancer</subject><subject>Ovarian carcinoma</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Survival</subject><subject>Tumorigenesis</subject><subject>Tumors</subject><issn>0250-7005</issn><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpFkMtOwzAQRS0EoqXwAWyQJdYpHjuO4yUKLVQqahewthzHQamoHeyEx9-TlgKbmVmce0c6CF0CmVLIBbvRrmuMdsHGKVAqxBEag5CQCM7IMRoTykkiCOEjdBbjhpAskzk7RSMqmUgzycdILf0Hnn22Q0VsvMO-xsVdmuJFxNrhhatsa4fhOjzXpvNhB6z9sNfBvzgfm4gbh1fvOjQD_9ibxvk-4kKH3bXV5-ik1q_RXhz2BD3PZ0_FQ7Jc3S-K22VimKBdQqu6lLzixuS1rvLcgOTGEk4YiFKmWuRpZbMqK6UVtRbUggUOwFhpDQdq2QRd__S2wb_1NnZq4_vghpeKAhMAPGVyoOCHMsHHGGyt2tBsdfhSQNReqfpXqvZKh8zVobkvt7b6S_w6ZN-AS3R9</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Matuura, Hiroko</creator><creator>Miyamoto, Morikazu</creator><creator>Takano, Masashi</creator><creator>Soyama, Hiroaki</creator><creator>Aoyama, Tadashi</creator><creator>Yoshikawa, Tomoyuki</creator><creator>Kato, Kento</creator><creator>Sakamoto, Takahiro</creator><creator>Kuwahara, Mika</creator><creator>Takasaki, Kazuki</creator><creator>Ishibashi, Hiroki</creator><creator>Iwahashi, Hideki</creator><creator>Tsuda, Hitoshi</creator><creator>Furuya, Kenichi</creator><general>International Institute of Anticancer Research</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20180201</creationdate><title>Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma</title><author>Matuura, Hiroko ; Miyamoto, Morikazu ; Takano, Masashi ; Soyama, Hiroaki ; Aoyama, Tadashi ; Yoshikawa, Tomoyuki ; Kato, Kento ; Sakamoto, Takahiro ; Kuwahara, Mika ; Takasaki, Kazuki ; Ishibashi, Hiroki ; Iwahashi, Hideki ; Tsuda, Hitoshi ; Furuya, Kenichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-2dfb95d5cc8fad88c195ce050317b94a784de6d6b9e7fa72e1e151133bec512e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Benign</topic><topic>Carcinogenesis</topic><topic>Carcinogens</topic><topic>CD44 antigen</topic><topic>Medical prognosis</topic><topic>Metastases</topic><topic>Ovarian cancer</topic><topic>Ovarian carcinoma</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Survival</topic><topic>Tumorigenesis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matuura, Hiroko</creatorcontrib><creatorcontrib>Miyamoto, Morikazu</creatorcontrib><creatorcontrib>Takano, Masashi</creatorcontrib><creatorcontrib>Soyama, Hiroaki</creatorcontrib><creatorcontrib>Aoyama, Tadashi</creatorcontrib><creatorcontrib>Yoshikawa, Tomoyuki</creatorcontrib><creatorcontrib>Kato, Kento</creatorcontrib><creatorcontrib>Sakamoto, Takahiro</creatorcontrib><creatorcontrib>Kuwahara, Mika</creatorcontrib><creatorcontrib>Takasaki, Kazuki</creatorcontrib><creatorcontrib>Ishibashi, Hiroki</creatorcontrib><creatorcontrib>Iwahashi, Hideki</creatorcontrib><creatorcontrib>Tsuda, Hitoshi</creatorcontrib><creatorcontrib>Furuya, Kenichi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matuura, Hiroko</au><au>Miyamoto, Morikazu</au><au>Takano, Masashi</au><au>Soyama, Hiroaki</au><au>Aoyama, Tadashi</au><au>Yoshikawa, Tomoyuki</au><au>Kato, Kento</au><au>Sakamoto, Takahiro</au><au>Kuwahara, Mika</au><au>Takasaki, Kazuki</au><au>Ishibashi, Hiroki</au><au>Iwahashi, Hideki</au><au>Tsuda, Hitoshi</au><au>Furuya, Kenichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>38</volume><issue>2</issue><spage>717</spage><pages>717-</pages><issn>0250-7005</issn><eissn>1791-7530</eissn><abstract>To determine whether CD44, which is associated with tumor growth and metastasis, is related to carcinogenesis and prognosis in ovarian mucinous carcinomas (MACs). Tissue blocks from 71 patients with benign mucinous ovarian tumors were used in the study: 35 were from patients with borderline mucinous ovarian tumors, and 60 from patients with MACs. Immunochemical analysis was performed to evaluate the expression of CD44 and examine its association with tumorigenesis and survival. Compared to benign tumors, borderline tumors had high CD44 expression levels (p=0.047). Conversely, MACs had lower expression than borderline tumors (p=0.032). Progression-free and overall survival of patients with MAC with low CD44 expression were worse than those of patients with high expression (p=0.04 and p=0.02, respectively). Malignant transformation of mucinous tumors is associated with changes in CD44 expression, with low expression level being a prognostic factor in MAC.</abstract><cop>Greece</cop><pub>International Institute of Anticancer Research</pub><pmid>29374695</pmid><doi>10.21873/anticanres.12277</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0250-7005
ispartof Anticancer research, 2018-02, Vol.38 (2), p.717
issn 0250-7005
1791-7530
language eng
recordid cdi_proquest_journals_2137115439
source Free E-Journal (出版社公開部分のみ）
subjects Benign
Carcinogenesis
Carcinogens
CD44 antigen
Medical prognosis
Metastases
Ovarian cancer
Ovarian carcinoma
Patients
Prognosis
Survival
Tumorigenesis
Tumors
title Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T01%3A11%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20Expression%20of%20CD44%20Is%20an%20Independent%20Factor%20of%20Poor%20Prognosis%20in%20Ovarian%20Mucinous%20Carcinoma&rft.jtitle=Anticancer%20research&rft.au=Matuura,%20Hiroko&rft.date=2018-02-01&rft.volume=38&rft.issue=2&rft.spage=717&rft.pages=717-&rft.issn=0250-7005&rft.eissn=1791-7530&rft_id=info:doi/10.21873/anticanres.12277&rft_dat=%3Cproquest_cross%3E2137115439%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-2dfb95d5cc8fad88c195ce050317b94a784de6d6b9e7fa72e1e151133bec512e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2137115439&rft_id=info:pmid/29374695&rfr_iscdi=true